A key opinion leader examines the combination therapy of amivantamab and lazertinib in the CHRYSALIS-2 study for treatment-naïve patients or those with 2 or more prior lines of therapy, and its ...
Quizartinib for Newly Diagnosed FLT3-Internal Tandem Duplication–Negative AML: The Randomized, Double-Blind, Placebo-Controlled, Phase II QUIWI Study CHRYSALIS-2 Cohort C enrolled participants with ...
A spacecraft named Chrysalis could one day carry 2,400 people to Alpha Centauri, the closest star system to our own. This interstellar voyage, estimated to take 400 years, would be a one-way adventure ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results